Week 7: Diabetes Type 2

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/60

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 10:01 PM on 9/20/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

61 Terms

1
New cards

What is Type II diabetes?

Gradual loss of peripheral insulin sensitivity with beta-cell dysfunction, leading to hyperglycemia

2
New cards

What causes hyperglycemia in Type II diabetes?

Beta cells cannot produce/release enough insulin to overcome peripheral insulin resistance

3
New cards

Pathology in Type II diabetes:

Insulin resistance + beta-cell failure

4
New cards

Treatments for Type II diabetes:

Lifestyle changes, oral anti diabetic drugs, and sometimes insulin

5
New cards

What are the major Type II diabetes drug classes?

Insulin secretagogues, alpha-glucosidase inhibitors, biguanides, thiazolidinediones, incretin analogues/DPP-4 inhibitors, and insulin

6
New cards

What are the initial tx choice for Type II diabetes drugs?

Metformin and sulfonylureas

7
New cards

Hypoglycemic Type II diabetes drugs:

Sulfonylureas and meglitinides

8
New cards

Antihyperglycemic Type II diabetes drugs:

Alpha-glucosidase inhibitors, biguanides, and thiazolidinediones

9
New cards

Sulfonylureas:

Insulin secretagogues that block pancreatic ATP-sensitive K+ channels to stimulate insulin release

10
New cards

Examples of sulfonylureas:

Glimepiride, glipizide, glyburide, tolbutamide

11
New cards

Meglitinides:

Fast onset insulin secretagogues that block pancreatic K+ channels to stimulate insulin release

12
New cards

Examples of meglitinides:

Repaglinide and nateglinide

13
New cards

What happens when beta-cell K+ channels close?

Depolarization → voltage-gated Ca2+ channels open → insulin exocytosis

14
New cards

What are side effects of sulfonylureas and meglitinides?

Hypoglycemia, weight gain, and CYP450 drug interactions

15
New cards

What are incretins?

GI hormones released with food that enhance insulin secretion

16
New cards

Incretin =

INtestine seCREtion INsulin

17
New cards

Incretin analogues:

drugs that bind incretin receptors and mimic incretin action to increase insulin secretion

18
New cards

Examples of incretin analogues:

Exenatide, Trulicity, Ozempic, Wegovy, Victoza

19
New cards

What are beneficial effects of incretin receptor agonists?

Reduced gastric emptying, increased satiety, weight loss

20
New cards

What are adverse effects of incretin receptor agonists?

Nausea, possible pancreatitis risk, decreased appetite, dysgeusia, dyspepsia, xerostomia

21
New cards

DPP-4 inhibitors:

Block DPP-4 enzyme to increase activation of endogenous incretins

22
New cards

What are examples of a DPP-4 inhibitor?

Sitagliptin, alogliptin, saxagliptin, linagliptin

23
New cards

Acarbose:

Alpha-glucosidase inhibitor that acts locally in the GI tract to reduce monosaccharide formation

24
New cards

Alpha-glucosidase inhibitors:

slow digestion/absorption of glucose by preventing formation of easily absorbed monosaccharides

25
New cards

Examples of alpha-glucosidase inhibitors:

Acarbose and miglitol

26
New cards

What are side effects of alpha-glucosidase inhibitors?

Gastric distress, diarrhea, flatulence

27
New cards

Metformin:

Biguanide that decreases hepatic/renal gluconeogenesis and increases insulin sensitivity

28
New cards

Actions of metformin (MOA still unclear):

Decreases gluconeogenesis, decreases glucose absorption, decreases plasma glucagon levels, increases glycolysis

29
New cards

Other uses for metformin:

Pre-diabetes, anti-cancer, anti-aging, neuroprotection, long-COVID prophylaxis

30
New cards

What are side effects of metformin?

GI distress, possible weight loss, lactic acidosis risk, water retention (peripheral swelling)

31
New cards

Thiazolidinediones:

Insulin sensitizers that activate PPAR and insulin responsive genes

32
New cards

What are examples of thiazolidinediones?

Pioglitazone and rosiglitazone

33
New cards

PPAR:

Peroxisome proliferator activated receptor

34
New cards

What are side effects of thiazolidinediones?

Fluid retention, weight gain, increased fracture risk, possible bladder cancer risk

35
New cards

Inhaled insulin:

Afrezza

Less control than injection, acute bronchospasm risk, not tested in children

36
New cards

What should a diabetic patient do before a dental appt?

Eat a balanced meal within 2 hours and take medications as prescribed

37
New cards

What appt timing is preferred for diabetic patients?

Early morning appointments

38
New cards

What complications are caused by loss of insulin or insulin sensitivity?

Hyperglycemia causing neuropathy, cardiovascular disease, nephrotoxicity, retinopathy, and impaired wound healing

39
New cards

What Type II drug classes target beta-cell dysfunction?

Sulfonylureas, meglitinides, DPP-4 inhibitors, GLP-1 analogs

40
New cards

What Type II drug classes target hepatic glucose overproduction?

Metformin, thiazolidinediones, DPP-4 inhibitors, GLP-1 analogs

41
New cards

What Type II drug classes target muscle/fat insulin resistance?

Thiazolidinediones and metformin

42
New cards

What Type II drug classes target gut glucose absorption?

Alpha-glucosidase inhibitors, GLP-1 analogs, pramlintide

43
New cards

Oxidative stress in Type II diabetes:

Hyperglycemia and insulin resistance cause mitochondrial dysfunction and ROS production

44
New cards

Why are beta cells prone to oxidative stress?

Beta cells have low antioxidant enzyme levels

45
New cards

What pathways are activated by ROS in beta cells?

JNK, p38, and PKC

46
New cards

How does ROS reduce insulin gene expression?

it suppresses PDX-1 and MafA binding to the insulin gene promoter

47
New cards

How does oxidative stress impair insulin secretion?

Reduces mitochondrial respiratory chain proteins and ATP production

48
New cards

ER stress in Type II diabetes:

Hyperinsulinemia increases insulin transcription/translation, causing unfolded or misfolded protein buildup in the ER

49
New cards

UPR:

Unfolded protein response triggered by PERK, IRE1, and ATF6 to help protein folding/degradation

50
New cards

What happens when UPR cannot handle ER protein load?

ER stress-mediated beta-cell dysfunction and death

51
New cards

Autophagy:

Catabolic degradation of dysfunctional proteins and defective cellular components

52
New cards

Autophagy in Type II diabetes:

Initially protective against oxidative/ER stress, but persistent metabolic stress causes dysregulation and beta-cell dysfunction/death

53
New cards

Islet inflammation:

Macrophage infiltration with cytokine/chemokine release that contributes to beta-cell dysfunction/death

54
New cards

What transcription factor is involved in islet inflammation?

NF-κB

55
New cards

What cytokines can beta cells produce in Type II diabetes?

IL-1β, IFNγ, TNFα, and IL-6

56
New cards

What can proinflammatory signals activate in beta cells?

Apoptotic mechanisms, ER stress, and UPR

57
New cards

Islet amyloid:

Pathologic pancreatic lesion formed by abnormal aggregation of islet amyloid polypeptide

58
New cards

What percent of Type II diabetes patients have islet amyloid?

More than 90%

59
New cards

Islet amyloid polypeptide:

Beta-cell hormone coproduced and cosecreted with insulin

60
New cards

What does increased islet amyloid deposition correlate with?

Decreased beta-cell mass and insulin production

61
New cards

How do GLP-1 receptor agonists and DPP-4 inhibitors help beta cells?

Enhance beta-cell proliferation/function through EGFR-mediated PI3K/Akt and cAMP/PKA pathways